Swiss National Bank’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-69,957
| Closed | -$658K | – | 2539 |
|
|
2020
Q3 | $658K | Buy |
69,957
+1,800
| +3% | +$17.1K | ﹤0.01% | 2284 |
|
|
2020
Q2 | $521K | Buy |
68,157
+3,700
| +6% | +$28.3K | ﹤0.01% | 2375 |
|
|
2020
Q1 | $398K | Hold |
64,457
| – | – | ﹤0.01% | 2267 |
|
|
2019
Q4 | $784K | Hold |
64,457
| – | – | ﹤0.01% | 2266 |
|
|
2019
Q3 | $744K | Hold |
64,457
| – | – | ﹤0.01% | 2210 |
|
|
2019
Q2 | $644K | Buy |
64,457
+1,500
| +2% | +$16.2K | ﹤0.01% | 2334 |
|
|
2019
Q1 | $811K | Buy |
62,957
+2,000
| +3% | +$29.8K | ﹤0.01% | 2182 |
|
|
2018
Q4 | $926K | Sell |
60,957
-2,500
| -4% | -$47.6K | ﹤0.01% | 2045 |
|
|
2018
Q3 | $1.27M | Hold |
63,457
| – | – | ﹤0.01% | 2010 |
|
|
2018
Q2 | $1.24M | Hold |
63,457
| – | – | ﹤0.01% | 2036 |
|
|
2018
Q1 | $1.28M | Buy |
63,457
+7,300
| +13% | +$123K | ﹤0.01% | 1932 |
|
|
2017
Q4 | $744K | Hold |
56,157
| – | – | ﹤0.01% | 2243 |
|
|
2017
Q3 | $1.04M | Hold |
56,157
| – | – | ﹤0.01% | 2042 |
|
|
2017
Q2 | $1.03M | Hold |
56,157
| – | – | ﹤0.01% | 2029 |
|
|
2017
Q1 | $1.27M | Hold |
56,157
| – | – | ﹤0.01% | 1865 |
|
|
2016
Q4 | $1.95M | Buy |
56,157
+2,000
| +4% | +$59.8K | ﹤0.01% | 1568 |
|
|
2016
Q3 | $1.33M | Sell |
54,157
-2,000
| -4% | -$50K | ﹤0.01% | 1792 |
|
|
2016
Q2 | $1.34M | Hold |
56,157
| – | – | ﹤0.01% | 1783 |
|
|
2016
Q1 | $1.27M | Buy |
56,157
+11,900
| +27% | +$282K | ﹤0.01% | 1757 |
|
|
2015
Q4 | $1.34M | Hold |
44,257
| – | – | ﹤0.01% | 1603 |
|
|
2015
Q3 | $1.76M | Buy |
44,257
+14,757
| +50% | +$916K | ﹤0.01% | 1397 |
|
|
2015
Q2 | $2.04M | Hold |
29,500
| – | – | 0.01% | 1297 |
|
|
2015
Q1 | $1.61M | Buy |
29,500
+11,100
| +60% | +$529K | ﹤0.01% | 1443 |
|
|
2014
Q4 | $784K | Hold |
18,400
| – | – | ﹤0.01% | 1872 |
|
|
2014
Q3 | $587K | Hold |
18,400
| – | – | ﹤0.01% | 2003 |
|
|
2014
Q2 | $381K | Buy |
18,400
+2,600
| +16% | +$48K | ﹤0.01% | 2303 |
|
|
2014
Q1 | $306K | Buy |
15,800
+3,200
| +25% | +$68K | ﹤0.01% | 2321 |
|
|
2013
Q4 | $306K | Hold |
12,600
| – | – | ﹤0.01% | 2259 |
|
|
2013
Q3 | $271K | Hold |
12,600
| – | – | ﹤0.01% | 2264 |
|
|
2013
Q2 | $280K | Buy |
+12,600
| New | +$278K | ﹤0.01% | 2245 |
|
Swiss National Bank's AMAG Position: Q4 2020 in Review
Swiss National Bank sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 69,957 shares — an estimated $658K sold.
Swiss National Bank first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $2.04M in Q2 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Swiss National Bank reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Swiss National Bank sold 69,957 AMAG Pharmaceuticals shares in Q4 2020, an estimated $658K.
- Swiss National Bank first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- Swiss National Bank's AMAG Pharmaceuticals position peaked at $2.04M in Q2 2015.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Swiss National Bank's 13F filing for Q4 2020, filed 5 Feb 2021.